A monoclonal antibody, SEl, which specifically reacted with rat hepatic sinusoidal endothelial cells (HSE), was established with eluttiator-separated HSE as immunogen. No aossreactivity was observed with other types of endothelial cells or non-endothelial cells. By immunoelectron microscopy, the antigen recognized by MAb SE-1 was localized to the membrane surface of HSE. Immunoblot analysis revealed that SE-1 recognized a single 45 band. Although the SE1 an-tigen is not yet characterized, the above evidence strongly suggests that it is related to the specific fwction of HSE. Therefore, SE-1 may be a useful marker to study the role of HSE in various pathophysiological conditions of the liver. Cytochem 41:1253-1257, 1993) 
Introduction
Among the vascular endothelial cells, hepatic sinusoidal endothelial (HSE) cells are morphologically unique because they have open fenestrations in their cytoplasm and lack basal lamina (1) . This unique structure is assumed to facilitate the exchange and transport of various substances between blood and hepatocytes through the space of Disse. Recently, it has been suggested that the formation of this structure is regulated by hepatocyte-related soluble factors or by the extracellular matrix (2,3).
However, in pathologically abnormal livers, such as those with alcohol injury or cirrhosis, decreases in the size and number of fenestrations and the appearance of basal lamina have been observed (4) (5) (6) . These findings indicate that the structure and function of HSE cells may be closely associated with physiological and pathological conditions of the liver. Therefore, study of the role and function of HSE cells would help us to understand the pathological changes that occur in liver disease. For this study, a phenotypic marker specific to the HSE cells but not to other types of vascular endothelial cells would be useful.
Therefore, we prepared a new monoclonal antibody (MAb) that specifically recognized rat HSE cells, using elutriator-separated endothelial cells as immunogens. In this study we discuss the histo- chemical and ultrastructural localization of the antigen recognized by this MAb and its possible function.
Materials and Methods
Immunogen Preparation and Immunization. Female Fischer 344 (F344) rats (Charles River Japan; Kanagawa, Japan), weighing 150-200 g, were used for immunogen preparation. Liver non-parenchymal cells were separated by centrifugation after 0.02% collagenase (Yakult Pharmaceutical; Tokyo, Japan) perfusion (7) . Thereafter, HSE cells were prepared by centrifugal elutriation using aJE-6 elutriator rotor (Beckman Instruments; Palo Alto, CA) at a speed of 2500 rpm and a flow rate of 20 ml/min according to the method of Knook and Sleyster (8), with slight modifications. The purity of the separated HSE cells was examined by electron microscopy and was determined to be more than 90%. Balb/c mice (Charles River Japan) were immunized IP with 2 x lo7 endothelial cells in PBS (80-9096 viable cells judged by uypan blue dye exclusion test). The mice were boosted twice IP and once IV at 1-week intervals without adjuvant, according to the method previously described (9) .
Cell Fusion and Purification of Monoclonal Antibody. Three days after the final boost, the immunized mice were sacrificed and their spleen cells (approximately 1 x lo8) were fused with mouse myeloma cells (NS-1, 3.6 x lo7 cells) using polyethylene glycol-4000 according to the protocol described by Kohler and Milstein (10) . The fused cells were selected in 96well tissue culture plates in RPMI 1640 (Sigma; St Louis, MO) containing 20% fetal bovine serum and hypoxanthin-aminopterin-thymidine (Sigma). Seven to 14 days after the fusion, culture supernatants from the proliferating clones were immunohistochemically screened, using frozen liver sections fixed in cold acetone for 15 min. Hybridomas producing antibodies were cloned by three times limiting dilution. Concentration of the MAb was performed by ammonium sulfate precipitation of the culture supernatant of the hybridoma. The precipitate was dissolved in PBS and dialyzed against PBS. The antibody isorype was determined with a mouse monoclonal kit (Amersham Japan; Tokyo, Japan).
Immunohistochemical Staining. Female F344 rat liver was fixed in cold acetone after brief perfusion with PBS through the portal vein and was embedded in soft paraffin. Tissues of brain, lung, aorta. kidney, spleen, adrenal gland, and intestine were also fixed in cold acetone for immunohistochemical analysis. Paraffin sections were deparaffinized in benzene for 30 min and processed for immunohistochemical staining. Before incubation with primary antibodies. the tissue sections were placed in 5 mM periodic acid in PBS for 10 min at room temperature to eliminate endogenous peroxidase activity. Then they were incubated with MAb SE-I at various dilutions or with rabbit antibody against Factor VIII-related antigen (DAKO Japan: Kyoto. Japan) for 2 hr at room temperature. The tissue slides were washed in cold PBS for IS min and incubated with peroxidaseconjugated rabbit anti-mouse IgG (DAKO Japan) or peroxidase-conjugated goat anti-rabbit IgG as second antibody for 2 hr. After washing in PBS. they were immersed in 0.02% 3,3'-diaminobenzidine4HCI (DAB) (Katayama Chemical: Osaka, Japan) and 0.005% H202 in PBS for visualization of specific reaction. Control slides were incubated with non-immune mouse serum as a primary antibody, Immunoelectron Microscopic Examination. Female F344 rat livers were fixed by perfusion of periodate-lysine-paraformaldehyde (PLP) solution through the portal vein and pieces of the fixed liver tissue were immersed in PLP solution for an additional24 hr at 4'C. Approximately 50-pm liver slices were made with a Micro-Slicer DTK-2000 (Dosaka EM: Kyoto. Japan) after rinsing with PBS for 15-30 min. The liver slices were rinsed again with PBS for 15 min, incubated with SE-1 for 6 hr at room temperature. and immunosrained as described above. Then they were post-fixed in a 1% osmium solution, dehydrated in an ethanol series, and embedded in epon. Ultra-thin sections counterstained with lead citrate were examined with a JEMlOOc electron microscope.
Immunoblot Analysis. HSE cells isolated from female F344 rat liver were sonicated in 50 mM Tris-HCI for 30 sec at 4%. After addition of an equal volume of 20% sucrose solution. the lysates were centrifuged for 30 . < . ?
min at 15,000 rpm. The pellets were dissolved in a sample buffer consisting of 125 mM Tris-HCI, pH 6.8. 4 % SDS. 20% glycerol, and 0.02% bromophenol blue (BPB). and were heated in boiling water for 5 min. They were separated by electrophoresis in a 10-20% SDS-polyacrylamide gradient gel (Daiichi Pure Chemicals: Tokyo, Japan). For reducing, a sample buffer with 750 mM of 2-mercaptoerhanol (Katayama Chemical: Osaka. Japan) was used. After electrophoretic transfer, the nitrocellulose membrane was treated with 1% PBS containing 0.05% Tween-20 and 5 % non-fat milk powder solution to minimize nonspecific binding of antibody. The membrane was immunostained for SE-1 by incubating with SE-I for 2 hr at room temperature, followed by incubation with peroxidase-conjugated rabbit antimouse IgG. Staining with DAB was performed as described above. The molecular weight was estimated with a molecular weight marker kit (Bio-Rad Laboratories; Richmond, CA).
Results
More than 100 antibody-producing clones were screened. Among them, o n e M A b showed a specific reaction with HSE cells; this was designated as SE-1. T h e subclass of this antibody was confirmed as IgGza, K type. Since SE-I was found to be applicable to the soft paraffin-embedded tissues after acetone fixation. soft-paraffin tissue sections were used for t h e following light microscopic examination.
Immunohistochemical staining of the liver tissues clearly demonstrated that immunoreactivity for SE-1 was detected only in HSE cells a n d not in the endothelium of portal vein, hepatic artery, a n d central vein (Figure 1) . Conversely, immunoreactivity for Factor VIIIrelated antigen was absent in HSE cells b u t was present in other liver endothelial cells ( Figure 2 ). Control staining with non-immune mouse serum as primary antibody showed n o positive staining.
T h e results of immunohistochemical staining for SE-1 a n d Factor VIII-related antigen in t h e various tissues are summarized in Table 1 . SE-1 reacted only with HSE cells. No endothelial cells or other types of cells examined were positive for SE-I. T h e species specificity of SE-1 was also examined. HSE cells of Fischer 344, Sprague-Dawley. and Wistar rats reacted with SE-1, but those of mouse and human did not show any positive reaction. Although the immunogen was prepared from female rats, there was no difference in the reactivity of SE-1 between males and females. Under immunoelectron microscopic inspection, the positive reaction of SE-1 to HSE cells was confirmed but neither Kupffer cells nor Ito cells showed a positive reaction. The reaction product was seen along the surface of the plasma membranes of HSE cells and the internal surface of pinocytotic vesicles (Figure 3 ). The reaction products were more abundant on the luminal surface of the endothelium but were also found on the hepatocyte-facing membrane. No other cytoplasmic organelles were positive for SE-1 in any ultrathin sections from different liver tissues. These results indicate membrane surface localization of the antigen epitope in HSE cells rather than poor penetration of the antibody. Table 1 
. Immunoreactivity of SE-1 and antibody against Factor VIII-related antigen (F VIII) in vascular endothelial cells of various tissues

Discussion
This study reports the establishment of a new MAb that specifically reacts with rat HSE cells. Although the functions of the antigen recognized by SE-1 are not yet known, we demonstrated the membrane surface localization of the antigen and its approximate molecular weight as 45 KD. Recently, several MAb against vascular endothelial cells have been established which have been shown to recognize a wide variety of antigens expressed on the endothelial cells in different tissues (11) (12) (13) (14) (15) (16) . Such antigenic heterogeneity indicates that vascular endothelial cells may have multiple specialized functions depending on their microenvironment.
Since MAb SE-1 stained only HSE cells among a wide variety of tissue type ( Table 1) . it is probable that the antigen recognized by SE-I relates to a function of only HSE cells. Nagura et al. (17) reported that human HSE cells were positively stained with MAb OKM-5, which recognizes monocyte-macrophage subsets. Scoazec and Feldmann (18) also showed specific localization of Fc receptors, CD14 and CD4 molecules, on HSE cells but not on other types of endothelial cells in human liver. These results showed that the HSE cell shares some antigens with immunoresponsive cells. In our study, however, SE-1 did not show any reaction with immunoresponsive cells in spleen or other tissues. Therefore, we suggest that the antigen recognized by SE-1 is not directly related to the immunological response of endothelial cells. The immunohistochemical staining pattern of SE-1 in the liver, i.e., positive for HSE cells but negative for portal and central vascular endothelial cells, is similar to that of the Fc receptor reported by Muro et al. (19) . However, unlike the Fc receptor, Kupffer cells were negative for SE-1, suggesting a difference between these two antigens.
It has become evident that HSE cells specifically express receptors for mannose, transferrin, and ceruloplasmin (20) (21) (22) . It should be determined whether or not SE-1 antigen is identical to these receptors.
The characteristic fenestral structure of HSE cells has long been known (I), but the mechanisms of fenestral formation are still uncertain. Modis and Martinez-Hernandez (2) recently demonstrated that implanted hepatocytes can modulate the vascular endothelial cells towards the sinusoid-type of morphology at the implanted site. The extracellular matrix has also been reported to play an es- sential role in regulating the phenotype of HSE cells (3). On the other hand, disappearance of the characteristic morphology of HSE cells, termed capillarization (23). has been observed in various pathological liver conditions (4) (5) (6) . This indicates that interaction with hepatocytes and/or liver extracellular matrices may be essential for maintaining the morphology and function of HSE cells. Therefore, it is of interest to determine whether or not expression of SE-1 antigen changes in pathological liver conditions. Further studies of the biochemical characteristics and functions of SE-1 antigen, and of its changes in pathological conditions of the liver, are now in progress.
